Urate oxidase (rasburicase) for treatment of severe acute gout: A case report

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 658-660

  Wipfler Freissmuth E ^a   Dejaco, C ^a   Duftner, C ^a   Gaugg, M ^a   Kriessmayr Lungkofler, M ^a   Schirmer, Michael ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Gout; Renal insufficiency; Urate oxidase

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; PREDNISONE; RASBURICASE; URIC ACID;

AGED; ANAMNESIS; ARTHRITIS; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GOUT; HUMAN; HYPERURICEMIA; KIDNEY FAILURE; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; AGED; ALLOPURINOL; FEMALE; GLOMERULONEPHRITIS; GOUT; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; NECROSIS; RENAL INSUFFICIENCY; TREATMENT OUTCOME; URATE OXIDASE; URIC ACID;

EID: 70350163049     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. MIKULS TR: Quality of care in gout: from measurement to improvement. Clin Exp Rheumatol 2007; 25 (Suppl. 47): 114-119
2. LAROSA C, MCMULLEN L, BAKDASH S et al.: Acute renal failure from xanthine nephropathy during management of acute leukaemia. Pediatr Nephrol 2007; 22: 132-135 (Pubitemid 46138373)
3. CHESON BD, DUTCHER BS: Managing malignancy-associated hyperuricemia with rasburicase. J Support Oncol 2005; 3: 117-24.
4. CAMMALLERI L, MALAGUARNERA M: Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci 2007; 4: 83-93.
5. VOGT B: Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transplant 2005; 20: 431-433
6. ODA M, SATTA Y, TAKENAKA O et al.: Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19: 640-653
7. MOOLENBURGH JD, REINDERS MK, JANSEN TL: Rasburicase treatment in severe tophaceous gout: a novel therapeutic option. Clin Rheumatol 2006; 25: 749-752 (Pubitemid 44120930)
8. SCHUMACHER HR, BECKER MA, WORTMANN RL et al.: Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 2008; 59: 1540-1548
9. DE ANGELIS S, NOCE A, DI RENZO L et al.: Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study. Eur Rev Med Pharmacol Sci 2007; 11: 179-184
10. SUNDY JS, BECKER MA, BARAF HSB et al.: Reduction of plasma urate levels following treatment of multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout. Results of a phase II randomized study. Arthritis Rheum 2008; 58: 2882-2891
11. RICHETTE P, BRIÈRE C, HOENEN-CLAVERT V et al.: Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. J Rheumatol 2007; 34: 2093-2098